Literature DB >> 30902441

Challenges and opportunities for the management of infectious diseases in Europes' prisons: evidence-based guidance.

Lara Tavoschi1, Éamonn O'Moore2, Dagmar Hedrich3.   

Abstract

People in prison have multiple complex health and social care needs. These are likely to be the result of a combination of overlapping, and sometimes interlinked, risk factors for infection, ill-health, and incarceration, such as problem drug use. Incarceration can represent a unique opportunity to make high-quality health care available to people in prison and to target socially deprived groups who are often medically underserved when living in the community they originate from. In recent years, international and European institutions have increasingly acknowledged the importance of treating prison health as an inseparable component of public health. However, numerous challenges hamper the successful implementation of such a concept, including the need for evidence-based decision making, intersectoral partnerships, and better monitoring systems. New initiatives are ongoing in the EU that might contribute to bring about positive changes, such as the publication of the first evidence-based public health guidance on prevention and control of communicable diseases in prison settings.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 30902441     DOI: 10.1016/S1473-3099(18)30756-4

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  2 in total

1.  COVID-19 outbreak investigation and response in a penitentiary setting: the experience of a prison in Italy, February to April 2020.

Authors:  Ruggero Giuliani; Cristina Cairone; Lara Tavoschi; Laura Ciaffi; Teresa Sebastiani; Raffaella Bartolotti; Silvia Mancini; Laura Cremonini; Roberto Ranieri
Journal:  Euro Surveill       Date:  2021-09

2.  Hepatitis C virus infection in EU/EEA and United Kingdom prisons: opportunities and challenges for action.

Authors:  Aya Olivia Nakitanda; Linda Montanari; Lara Tavoschi; Antons Mozalevskis; Erika Duffell
Journal:  BMC Public Health       Date:  2020-11-09       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.